Presidential Symposium: Th2 Immune Response Modifiers for Severe Airway Diseases
Saturday, February 21, 2015: 10:45 AM-12:00 PM
Convention Center, Level Three, General Assembly Theater B
1.25 CME/ 1.50 CE
James T. Li , MD PhD FAAAAI

Learning Objectives

  1. Describe asthma and COPD phenotypes and the implications for personalized medicine
  2. Describe and discuss the therapeutic utility of targeting Th2-high phenotype in asthma
  3. Discuss how COPD can have similar pathologic mechanisms and therapeutic targets as asthma
10:45 AM
Phenotypes in Asthma and COPD: Therapeutic Implications for Personalized Medicine
Sally E. Wenzel, MD FAAAAI
11:05 AM
Targeting of Th2-high Phenotype in Asthma
Thomas B. Casale, MD FAAAAI
11:25 AM
Th2 Cytokine Antagonists in COPD
Reynold A. Panettieri Jr., MD
11:45 AM
Question & Answer Panel Discussion
See more of: Symposia